John C. Davis
Impact in
- Rheumatology top 0.02%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Immunology top 0.5%
- Psoriasis: Treatment and Pathogenesis
- T-cell and B-cell Immunology
Papers in
- Rheumatology 64
- Spondyloarthritis Studies and Treatments 45
- Systemic Lupus Erythematosus Research 13
- Rheumatoid Arthritis Research and Therapies 11
-
- Vasculitis and related conditions 19
- Co-authors
- Désirée van der Heijde (14 shared papers)Jürgen Braun (12 shared papers)Joachim Sieper (8 shared papers)Jennifer D. Gorman (3 shared papers)Kenneth E. Sack (1 shared paper)John D. Reveille (13 shared papers)Maxime Dougados (6 shared papers)Robert Landewé (4 shared papers)
- Journals
- Annals of the Rheumatic Diseases (12 papers)The Lancet (10 papers)Blood (6 papers)Arthritis Care & Research (6 papers)Clinical Endocrinology (4 papers)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
John C. Davis
211 papers receiving 10.4k citations
John C. Davis's Hit Papers
Peers
Comparison fields: 5 of 172
- Rheumatology 6.5k
- Immunology 2.6k
- Hematology 1.2k
- Pulmonary and Respiratory Medicine 1.7k
- Nephrology 313
Countries citing papers authored by John C. Davis
This map shows the geographic impact of John C. Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Davis more than expected).
Fields of papers citing papers by John C. Davis
This network shows the impact of papers produced by John C. Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Davis. The network helps show where John C. Davis may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 216 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis Hit paper breakdown → | 2008 | 734 |
| 2 | Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial Hit paper breakdown → | 2006 | 665 |
| 3 | Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial Hit paper breakdown → | 2003 | 586 |
| 4 | Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α Hit paper breakdown → | 2002 | 552 |
| 5 | Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial Hit paper breakdown → | 2008 | 448 |
| 6 | Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept Hit paper breakdown → | 2008 | 409 |
| 7 | 2001 | 354 | |
| 8 | 2005 | 294 | |
| 9 | A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE) Hit paper breakdown → | 2015 | 277 |
| 10 | 2002 | 266 | |
| 11 | 2007 | 204 | |
| 12 | 2005 | 201 | |
| 13 | 2007 | 186 | |
| 14 | 1999 | 185 | |
| 15 | 2005 | 155 | |
| 16 | 2005 | 146 | |
| 17 | 2007 | 145 | |
| 18 | 2005 | 142 | |
| 19 | 2006 | 141 | |
| 20 | 2008 | 140 |
About John C. Davis
John C. Davis is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine, Surgery, Immunology and Molecular Biology, having authored 216 papers that have together received 11.0k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (45 papers), Vasculitis and related conditions (19 papers), Systemic Lupus Erythematosus Research (13 papers), Rheumatoid Arthritis Research and Therapies (11 papers), Sperm and Testicular Function (10 papers), Hematopoietic Stem Cell Transplantation (9 papers), Metabolism and Genetic Disorders (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). The work is most often cited by research in Rheumatology (6.5k citations), Immunology (2.6k citations), Hematology (1.2k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Nephrology (313 citations). John C. Davis has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Désirée van der Heijde, Jürgen Braun, Joachim Sieper, Jennifer D. Gorman, Kenneth E. Sack, John D. Reveille, Maxime Dougados, Robert Landewé, S van der Linden and H. L. Sheehan. Their work appears in journals such as Annals of the Rheumatic Diseases, The Lancet, Blood, Arthritis Care & Research and Clinical Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.